Cold agglutinins are a potential danger to patients who must be subjected to hypothermia. A patient with a cold agglutinin of moderate titer but broad thermal amplitude was to undergo hypothermia during aortic valve replacement. He was managed preoperatively with an eight-liter plasma exchange by continuous-flow centrifugation to remove the cold agglutinin. There were no adverse effects during or after hypothermia.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1046/j.1537-2995.1980.20380214906.x | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!